ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway

Table 1 Clinicopathological characteristics of 148 GC patients according to ERp29 expression

Characteristic	ERp29		P value*	r _s value
Characteristic	Low expression (n = 96)	High expression (n = 52)	P value*	r _s value
Normal vs cancer
Normal	47	101	<0.001	−0.331^#
Cancer	96	52
Age(years)
<60	36	16	0.413	0.059
≥ 60	60	36	0.413
Gender
Females	31	8	0.026	-
Males	65	44	0.026
TNM stage
II	21	27	0.001	−0.286^#
III	66	22
IV	9	3
TNM stage
I, II	21	27	<0.001	−0.306^#
III, IV	75	25	<0.001
T classification
T2	6	5	0.011	−0.237^#
T3	32	29
T4	58	18
N classification
N0	13	12	0.007	−0.257^#
N1	15	18
N2	20	8
N3	48	14
Lymphatic metastasis
Yes	83	40	0.139	−0.121
No	13	12	0.139
Distant metastases
Yes	9	3	0.541	−0.063
No	87	49	0.541
Venous invasion
Yes	48	20	0.179	−0.066
No	87	49	0.179
Locattion
Up	24	13	0.179	0.134
Middle	34	8
Lower	30	26
Pathological differentiation
Un−/Poorly	70	33	0.233	−0.111
Moderrately/Well	26	19	0.233
Perineural invasion
Yes	26	19	0.233	0.111
No	70	33	0.233

*P value was determined using Pearson’s chi-square test; r _s value was determined by Spearman’s rank-order correlation, ^#: P < 0.05

ISSN: 1471-2407